The role of incretin therapy at different stages of diabetes.

The review of diabetic studies : RDS

Volumn 8, Issue 3, 2011, Pages 323-338

  Cernea, Simona ^a  

^a Emergency Clinical Hospital   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1; INCRETIN;

CLINICAL TRIAL (TOPIC); DISEASE COURSE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; REVIEW;

CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; PREDIABETIC STATE;

EID: 84856024160     PISSN: None     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2011.8.323     Document Type: Review

References (0)